|
|
Article: Scandipharm Eases Financial Burden for Newly-Diagnosed CF Patient.
- Article from:
- PR Newswire
- Article date:
- October 19, 1998
CopyrightCOPYRIGHT 1998 PR Newswire Association LLC. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
BIRMINGHAM, Ala., Oct. 16 /PRNewswire/ -- Scandipharm, Inc. announced plans to introduce an innovative, new program that will help ease the financial burden of infant patients diagnosed with cystic fibrosis (CF). Beginning in January 1999, the CareFirst For CF(TM) program will provide at no cost certain medications for CF patients under two years of age. Company President and CEO Thomas S. Stribling made the announcement today at the 12th Annual North American Cystic Fibrosis Conference in Montreal, Quebec, Canada.
Families of CF patients experience tremendous emotional strain and formidable issues in the early days of diagnosis. Once the emotion subsides, the ...